Date | Time | Source | Headline | Symbol | Company |
06/07/2024 | 2:15PM | iHub Newswire | FeaturedDaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio | | |
06/07/2024 | 1:00AM | GlobeNewswire Inc. | Ipsen et Marengo Therapeutics annoncent la conclusion d’un second partenariat stratégique afin de faire progresser les actifs « T-Cell Engager » de précision de la plateforme TriSTAR de Marengo | EU:IPN | Ipsen SA |
06/07/2024 | 1:00AM | GlobeNewswire Inc. | Ipsen and Marengo Therapeutics announce second strategic partnership to advance precision T cell engagers from Marengo’s Tri-STAR platform | EU:IPN | Ipsen SA |
06/07/2024 | 1:00AM | GlobeNewswire Inc. | Ipsen and Marengo Therapeutics announce second strategic partnership to advance precision T cell engagers from Marengo’s Tri-STAR platform | EU:IPN | Ipsen SA |
06/06/2024 | 12:00PM | GlobeNewswire Inc. | Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social | EU:IPN | Ipsen SA |
06/06/2024 | 12:00PM | GlobeNewswire Inc. | Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital | EU:IPN | Ipsen SA |
06/06/2024 | 8:30AM | GlobeNewswire Inc. | Ipsen appoints Josep Catllà as EVP, Chief Corporate Affairs Officer | EU:IPN | Ipsen SA |
06/06/2024 | 8:30AM | GlobeNewswire Inc. | Ipsen appoints Josep Catllà as EVP, Chief Corporate Affairs Officer | EU:IPN | Ipsen SA |
06/06/2024 | 8:30AM | GlobeNewswire Inc. | Ipsen nomme Josep Catllà, en qualité de Vice-Président Exécutif, Chief Corporate Affairs Officer | EU:IPN | Ipsen SA |
06/05/2024 | 2:00AM | GlobeNewswire Inc. | Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with primary biliary cholangitis | EU:IPN | Ipsen SA |
06/03/2024 | 1:00AM | GlobeNewswire Inc. | Ipsen initiates a share buy-back program to cover its free employee share-allocation plan | EU:IPN | Ipsen SA |
06/03/2024 | 1:00AM | GlobeNewswire Inc. | Ipsen lance un programme de rachat d’actions pour couvrir son programme d’attribution d’actions gratuites aux salariés | EU:IPN | Ipsen SA |
05/30/2024 | 12:15PM | GlobeNewswire Inc. | Ipsen annonce le lancement d'une opération d’actionnariat salarié | EU:IPN | Ipsen SA |
05/30/2024 | 12:15PM | GlobeNewswire Inc. | Ipsen announces the launch of an employee shareholding plan | EU:IPN | Ipsen SA |
05/28/2024 | 12:00PM | GlobeNewswire Inc. | Assemblée Générale Annuelle d’Ipsen S.A. du 28 mai 2024 | EU:IPN | Ipsen SA |
05/28/2024 | 12:00PM | GlobeNewswire Inc. | Annual General Meeting of Ipsen S.A. held on 28 May 2024 | EU:IPN | Ipsen SA |
05/28/2024 | 1:00AM | GlobeNewswire Inc. | Descriptif du cadre réglementaire du programme de rachat d’actions soumis par le Conseil d’administration à l’approbation de l’Assemblée Générale Annuelle des actionnaires d’Ipsen S.A. du 28 mai 2024 | EU:IPN | Ipsen SA |
05/28/2024 | 1:00AM | GlobeNewswire Inc. | Description of the regulatory framework of the share repurchase program proposed by the Board of Directors to be approved at Ipsen S.A.’s Annual General Meeting on 28 May 2024 | EU:IPN | Ipsen SA |
05/07/2024 | 8:55AM | GlobeNewswire Inc. | IPSEN SA. - Modalités de mise à disposition et de consultation des documents préparatoires à l’Assemblée Générale Mixte du 28 mai 2024 | EU:IPN | Ipsen SA |
05/07/2024 | 8:55AM | GlobeNewswire Inc. | Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2024 Annual General Meeting | EU:IPN | Ipsen SA |
05/06/2024 | 12:00PM | GlobeNewswire Inc. | Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social | EU:IPN | Ipsen SA |
05/06/2024 | 12:00PM | GlobeNewswire Inc. | Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital | EU:IPN | Ipsen SA |
05/02/2024 | 1:30AM | GlobeNewswire Inc. | Ipsen appoints Keira Driansky as EVP, President of North America | EU:IPN | Ipsen SA |
05/02/2024 | 1:30AM | GlobeNewswire Inc. | Ipsen appoints Keira Driansky as EVP, President of North America | EU:IPN | Ipsen SA |
05/02/2024 | 1:30AM | GlobeNewswire Inc. | Ipsen nomme Keira Driansky, en qualité de Vice-Présidente Exécutive, et Présidente Amérique du Nord | EU:IPN | Ipsen SA |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l'exercice 2024 | EU:IPN | Ipsen SA |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance | EU:IPN | Ipsen SA |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance | EU:IPN | Ipsen SA |
04/22/2024 | 1:00AM | GlobeNewswire Inc. | Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases | EU:IPN | Ipsen SA |
04/22/2024 | 1:00AM | GlobeNewswire Inc. | Ipsen et Skyhawk Therapeutics annoncent la signature d'un accord de collaboration de recherche visant le ciblage d’ARN dans les maladies neurologiques rares | EU:IPN | Ipsen SA |